Delving into the Visual Function and Structural Changes of Patients in the Phase 1/2a OpRegen Study
Time: 9:30 am
day: Conference Day 1
Details:
- Receiving a program update from the OpRegen program
- Assessing the available clinical data to understand OpRegen safety and preliminary activity
- Understanding the potential benefit of optical coherence tomography for assessing OpRegen activity
